A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery

NCT02691026 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped Slow enrollment as a result of low incidence of MPNST and the COVID-19 pandemic.

Conditions

Interventions

Sponsor

Oslo University Hospital

Collaborators